Cancer Incidence and Mortality among Blacks, Queens County, 2005-2009
Source: New York State Cancer Registry
| Site of Cancer | Incidence | Mortality | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Males | Females | Males | Females | |||||||||
| Average Annual Cases | Rate per 100,000 Males | 95% CI (+/-) | Average Annual Cases | Rate per 100,000 Females | 95% CI (+/-) | Average Annual Deaths | Rate per 100,000 Males | 95% CI (+/-) | Average Annual Deaths | Rate per 100,000 Females | 95% CI (+/-) | |
| All Invasive Malignant Tumors | 1053.4 | 570.7 | 16.2 | 1004.6 | 355.0 | 9.9 | 295.6 | 182.5 | 9.9 | 356.0 | 126.2 | 5.9 |
| Oral cavity and pharynx | 23.8 | 11.5 | 2.1 | 11.8 | 4.1 | 1.1 | 8.0 | 4.1 | 1.3 | 2.2 | 0.7 | 0.4 |
| Esophagus | 9.8 | 5.9 | 1.8 | 7.4 | 2.6 | 0.8 | 7.6 | 4.4 | 1.5 | 4.4 | 1.5 | 0.6 |
| Stomach | 30.2 | 17.8 | 3.0 | 25.8 | 9.3 | 1.6 | 15.8 | 9.5 | 2.2 | 14.6 | 5.3 | 1.2 |
| Colorectal | 96.4 | 54.8 | 5.2 | 121.6 | 43.3 | 3.5 | 30.4 | 19.1 | 3.2 | 42.4 | 15.3 | 2.1 |
| Colon excluding rectum | 67.2 | 39.4 | 4.4 | 90.4 | 32.3 | 3.0 | 26.8 | 17.0 | 3.0 | 38.4 | 13.8 | 2.0 |
| Rectum & rectosigmoid | 29.2 | 15.5 | 2.6 | 31.2 | 11.1 | 1.7 | 3.6 | 2.1 | 1.0 | 4.0 | 1.5 | 0.7 |
| Liver / intrahepatic bile duct | 24.6 | 12.5 | 2.3 | 11.0 | 3.9 | 1.0 | 15.4 | 8.5 | 2.0 | 7.2 | 2.5 | 0.8 |
| Pancreas | 20.8 | 11.9 | 2.4 | 29.0 | 10.5 | 1.7 | 19.6 | 11.9 | 2.5 | 21.4 | 7.6 | 1.5 |
| Larynx | 13.4 | 7.3 | 1.8 | 3.8 | 1.3 | 0.6 | 5.8 | 2.9 | 1.1 | 1.8 | 0.6 | 0.4 |
| Lung and bronchus | 105.2 | 60.4 | 5.4 | 103.8 | 36.4 | 3.2 | 70.0 | 40.7 | 4.5 | 63.0 | 22.4 | 2.5 |
| Melanoma of the skin | 2.2 | 1.0 | 0.6 | 2.8 | 1.0 | 0.5 | 1.8 | 1.1 | 0.8 | 0.4 | 0.1 | 0.2 |
| Female breast | 302.4 | 105.7 | 5.4 | 67.8 | 23.6 | 2.5 | ||||||
| Cervix uteri | 30.0 | 10.7 | 1.7 | 8.2 | 2.8 | 0.9 | ||||||
| Corpus uterus and NOS | 82.6 | 28.4 | 2.8 | 20.2 | 7.1 | 1.4 | ||||||
| Ovary | 28.2 | 9.7 | 1.6 | 18.8 | 6.5 | 1.3 | ||||||
| Prostate | 486.2 | 255.0 | 10.6 | 51.6 | 38.3 | 4.9 | ||||||
| Testis | 3.0 | 1.4 | 0.7 | 0.4 | 0.2 | 0.3 | ||||||
| Urinary bladder (incl. in situ) | 33.0 | 20.6 | 3.3 | 18.6 | 6.7 | 1.4 | 7.0 | 5.4 | 1.9 | 6.0 | 2.2 | 0.8 |
| Kidney and renal pelvis | 33.4 | 17.0 | 2.7 | 23.2 | 8.2 | 1.5 | 5.6 | 3.5 | 1.4 | 4.6 | 1.6 | 0.7 |
| Brain and other nervous system | 11.0 | 5.7 | 1.6 | 11.0 | 4.2 | 1.1 | 3.6 | 2.0 | 1.0 | 3.6 | 1.3 | 0.6 |
| Thyroid | 6.4 | 3.1 | 1.1 | 26.6 | 9.5 | 1.6 | 0.2 | 0.1 | 0.2 | 1.8 | 0.6 | 0.4 |
| Hodgkin lymphoma | 6.6 | 3.2 | 1.1 | 6.4 | 2.5 | 0.9 | 0.2 | 0.1 | 0.2 | 0.8 | 0.3 | 0.3 |
| Non-Hodgkin lymphomas | 35.0 | 18.1 | 2.8 | 31.2 | 11.3 | 1.8 | 9.0 | 5.0 | 1.6 | 9.6 | 3.4 | 1.0 |
| Multiple myeloma | 25.8 | 14.4 | 2.6 | 22.0 | 7.6 | 1.4 | 10.0 | 5.9 | 1.7 | 10.4 | 3.6 | 1.0 |
| Leukemias | 18.0 | 10.2 | 2.2 | 17.8 | 6.5 | 1.4 | 8.4 | 5.3 | 1.7 | 8.2 | 3.0 | 0.9 |
Notes
- Incidence data are provisional, November 2011.
- Rates are per 100,000 persons, age-adjusted to the 2000 US standard population, with 95% confidence intervals.
- Rates based on fewer than 4 cases or deaths per year are unstable and should be used with caution. NOS = Not otherwise specified.
- NYSCR mortality statistics might differ slightly from official mortality statistics due to the availability of additional demographic information.
